CureVac NV Preliminary Phase 1 Data from Joint COVID-19 and Flu mRNA Vaccine Development Programs Transcript - Thomson StreetEvents

CureVac NV Preliminary Phase 1 Data from Joint COVID-19 and Flu mRNA Vaccine Development Programs Transcript

CureVac NV Preliminary Phase 1 Data from Joint COVID-19 and Flu mRNA Vaccine Development Programs Transcript - Thomson StreetEvents
CureVac NV Preliminary Phase 1 Data from Joint COVID-19 and Flu mRNA Vaccine Development Programs Transcript
Published Jan 06, 2023
12 pages (7836 words) — Published Jan 06, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of CVAC.OQ conference call or presentation 6-Jan-23 2:00pm GMT

  
Brief Excerpt:

...Operator Greetings. Welcome to CureVac's Preliminary Phase I Data from Joint COVID-19 and Flu mRNA Vaccine Development Program. This time all participant are in listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions). Please note this conference is being recorded. At this time, I'll now turn the conference over to Sarah Fakih, Vice President, Corporate Communications and Investor Relations. Ms. Fakih, you may now begin. Sarah Fakih ...

  
Report Type:

Transcript

Source:
Company:
CureVac NV
Ticker
CVAC.OQ
Time
2:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

CureVac NV Q3 2024 Earnings Call Transcript – 2024-11-12 – US$ 54.00 – Edited Transcript of CVAC.OQ earnings conference call or presentation 12-Nov-24 2:00pm GMT

CureVac NV Q3 2023 Earnings Call Transcript – 2023-11-14 – US$ 54.00 – Edited Transcript of CVAC.OQ earnings conference call or presentation 14-Nov-23 2:00pm GMT

CureVac NV at Bank of America Global Healthcare Conference Transcript – 2023-05-09 – US$ 54.00 – Edited Transcript of CVAC.OQ presentation 9-May-23 10:40pm GMT

CureVac NV Q4 2022 Earnings Call Transcript – 2023-04-25 – US$ 54.00 – Edited Transcript of CVAC.OQ earnings conference call or presentation 25-Apr-23 1:00pm GMT

CureVac NV Annual Shareholders Meeting Transcript – 2023-03-28 – US$ 54.00 – Edited Transcript of CVAC.OQ shareholder or annual meeting 28-Mar-23 10:59am GMT

CureVac NV Q3 2022 Earnings Call Transcript – 2022-11-16 – US$ 54.00 – Edited Transcript of CVAC.OQ earnings conference call or presentation 16-Nov-22 2:00pm GMT

CureVac NV Annual Shareholders Meeting Transcript – 2022-06-22 – US$ 54.00 – Edited Transcript of CVAC.OQ shareholder or annual meeting 22-Jun-22 12:00pm GMT

CureVac NV at JMP Securities Life Sciences Conference Transcript – 2022-06-15 – US$ 54.00 – Edited Transcript of CVAC.OQ presentation 15-Jun-22 1:30pm GMT

CureVac NV at Jefferies Healthcare Conference Transcript – 2022-06-09 – US$ 54.00 – Edited Transcript of CVAC.OQ presentation 9-Jun-22 1:30pm GMT

CureVac NV at Bank of America Healthcare Conference Transcript – 2022-05-10 – US$ 54.00 – Edited Transcript of CVAC.OQ presentation 10-May-22 3:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "CureVac NV Preliminary Phase 1 Data from Joint COVID-19 and Flu mRNA Vaccine Development Programs Transcript" Jan 06, 2023. Alacra Store. May 02, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/CureVac-NV-Preliminary-Phase-1-Data-from-Joint-COVID-19-and-Flu-mRNA-Vaccine-Development-Programs-T15434983>
  
APA:
Thomson StreetEvents. (2023). CureVac NV Preliminary Phase 1 Data from Joint COVID-19 and Flu mRNA Vaccine Development Programs Transcript Jan 06, 2023. New York, NY: Alacra Store. Retrieved May 02, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/CureVac-NV-Preliminary-Phase-1-Data-from-Joint-COVID-19-and-Flu-mRNA-Vaccine-Development-Programs-T15434983>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.